Clinical Trials in San Francisco

Showing 4461-4480 of 12,991 trials

THC Crossover Study

NCT04429568

This is a randomized, crossover study enrolling experienced dual cannabis-tobacco smokers (N=18) to describe the differences in THC and toxicant exposure, examining pharmacokinetic, subjective, and cardiovascular effects from smoking and vaping dry herb cannabis. This study will also examine the differences in toxicant exposure and cardiovascular disease risk between smoking cannabis and smoking tobacco cigarettes.

THCCannabisCannabis Smoking+6 more

University of California, San Francisco14 participantsStarted Oct 2020

San Francisco, California, United States • San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

NCT03551496

Single phased global, prospective, multicenter clinical trial designed to demonstrate a superior patency rate and acceptable safety in below the knee arteries with lesions treated with the DES BTK Vascular Stent System vs. percutaneous transluminal angioplasty (PTA).

Critical Limb Ischemia

Boston Scientific Corporation201 participantsStarted Aug 2018

Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States • San Francisco, California, United States +39 more locations

THC Crossover Study

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Find Trials by Condition in San Francisco

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management: An Extension Study

Research on Expecting Moms and Sleep Therapy

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

Pivot Breath Sensor Performance Study

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer